Moreover, there was no difference in RFS between presence and absence of TLS in patient with EGFR mutation, but in early-stage lung cancer without EGFR mutations, TLS + patients had better RFS than TLS- patients. The gene discussed is EGFR; the disease is lung carcinoma.